{"altmetric_id":14482081,"counts":{"readers":{"mendeley":13,"citeulike":0,"connotea":0},"total":{"posts_count":1},"policy":{"unique_users_count":1,"unique_users":["nap"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4e83cf058f6100021f0","authors":["Colucci WS"],"doi":"10.1016\/j.amjcard.2004.01.018","endpage":"16","first_seen_on":"2016-12-06T03:28:51+00:00","issns":["0002-9149","00029149"],"issue":"9A","journal":"American Journal of Cardiology","last_mentioned_on":1325376000,"links":["http:\/\/dx.doi.org\/10.1016\/j.amjcard.2004.01.018"],"pmid":"15144931","pubdate":"2004-05-05T23:00:00+00:00","publisher_subjects":[{"name":"Cardiovascular Medicine And Haematology","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"13","subjects":["cardiology"],"title":"Landmark study: the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study (CAPRICORN)","type":"article","volume":"93","mendeley_url":"http:\/\/www.mendeley.com\/research\/landmark-study-carvedilol-postinfarct-survival-control-left-ventricular-dysfunction-study-capricorn"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":7262568,"mean":6.3647833378992,"rank":1727125,"this_scored_higher_than_pct":63,"this_scored_higher_than":4601733,"rank_type":"exact","sample_size":7262568,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":217597,"mean":12.456512086619,"rank":73219,"this_scored_higher_than_pct":64,"this_scored_higher_than":141389,"rank_type":"exact","sample_size":217597,"percentile":64},"this_journal":{"total_number_of_other_articles":3701,"mean":4.6346875675676,"rank":920,"this_scored_higher_than_pct":59,"this_scored_higher_than":2206,"rank_type":"exact","sample_size":3701,"percentile":59},"similar_age_this_journal_3m":{"total_number_of_other_articles":85,"mean":8.1829523809524,"rank":49,"this_scored_higher_than_pct":41,"this_scored_higher_than":35,"rank_type":"exact","sample_size":85,"percentile":41}}},"demographics":{"users":{"mendeley":{"by_status":{"Student  > Doctoral Student":2,"Researcher":4,"Student  > Ph. D. Student":4,"Student  > Postgraduate":2,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":11,"Social Sciences":1,"Agricultural and Biological Sciences":1}}},"geo":{"mendeley":{"GB":1,"DE":1}}},"posts":{"policy":[{"title":"Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary","url":"https:\/\/www.nap.edu\/download\/13237","license":"public","citation_ids":[208844,1385126,1428599,14482075,716819,3653649,105420,496281,3090305,14482081,181068,386640,171073,14482084,15011682,4581355,4581355,4581355],"posted_on":"2012-01-01T00:00:00+00:00","source":{"name":"National Academies Press","description":"The US National Academies Press (NAP) was created by the National Academy of Sciences to publish the reports of the National Academies of Sciences, Engineering and Medicine, operating under a charter granted by the Congress of the United States. The NAP publishes on a wide range of topics in science, engineering, and medicine, providing authoritative information on important matters in science and health policy.","geo":{"country":"US"}},"page_url":"https:\/\/www.nap.edu\/catalog\/13237\/public-engagement-and-clinical-trials-new-models-and-disruptive-technologies","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-77d4235f916cd979b626dd78a0cea8981a54a7bc8673b5755f6066b6e99dd200.jpg"}}]}}